Evidence map›Paper›PMID 19808660›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.

Andrey Bozarov, Yu-Zhong Wang, Jun Ge Yu, Jacqueline Wunderlich, Hamdy H Hassanain, Mazin Alhaj, Helen J Cooke, Iveta Grants, Tianhua Ren, Fievos L Christofi

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Recent advances in small bowel diseases: Part II.World journal of gastroenterology · 2012
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andrey BozarovDept. of Anesthesiology, The Ohio State Univ., Columbus, 43210, USA.
Yu-Zhong Wang
Jun Ge Yu
Jacqueline Wunderlich
Hamdy H Hassanain
Mazin Alhaj
Helen J Cooke
Iveta Grants
Tianhua Ren
Fievos L Christofi
The Ohio State University · US

Funding

PURINERGIC REGULATION OF ENTERIC NEURAL REFLEXESR01DK044179 · NIDDK · OHIO STATE UNIVERSITY · PI CHRISTOFI, FEDIAS LEONTIOU · 1999 to 2011
$2.7M
COORDINATION OF MOTILITY AND SECRETIONR01DK057016 · NIDDK · OHIO STATE UNIVERSITY · PI COOKE, HELEN J · 2000 to 2004
$1.5M
INVERTED SPOT LASER SCANNING CONFOCAL MICROSCOPES10RR011434 · NCRR · OHIO STATE UNIVERSITY · PI CHRISTOFI, FEDIAS L. · 1996 to 1996
–
NCRR NIH HHS 1S10RR11434NIDDK NIH HHS DK57016NIDDK NIH HHS R01 DK44179-14
6 · The paper itself

Abstract

We tested the novel hypothesis that endogenous adenosine (eADO) activates low-affinity A3 receptors in a model of neurogenic diarrhea in the guinea pig colon. Dimaprit activation of H2 receptors was used to trigger a cyclic coordinated response of contraction and Cl(-) secretion. Contraction-relaxation was monitored by sonomicrometry (via intracrystal distance) simultaneously with short-circuit current (I(sc), Cl(-) secretion). The short interplexus reflex coordinated response was attenuated or abolished by antagonists at H2 (cimetidine), 5-hydroxytryptamine 4 receptor (RS39604), neurokinin-1 receptor (GR82334), or nicotinic (mecamylamine) receptors. The A1 agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) abolished coordinated responses, and A1 antagonists could restore normal responses. A1-selective antagonists alone [8-cyclopentyltheophylline (CPT), 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX), or 8-cyclopentyl-N(3)-[3-(4-(fluorosulfonyl)benzoyloxy)propyl]-xanthine (FSCPX)] caused a concentration-dependent augmentation of crypt cell secretion or contraction and acted at nanomolar concentrations. The A3 agonist N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA) abolished coordinated responses and the A3 antagonist 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(+/-)-dihydropyridine-3,5-dicarboxylate (MRS1191) could restore and further augment responses. The IB-MECA effect was resistant to knockdown of adenosine A1 receptor with the irreversible antagonist FSCPX; the IC(50) for IB-MECA was 0.8 microM. MRS1191 alone could augment or unmask coordinated responses to dimaprit, and IB-MECA suppressed them. MRS1191 augmented distension-evoked reflex I(sc) responses. Adenosine deaminase mimicked actions of adenosine receptor antagonists. A3 receptor immunoreactivity was differentially expressed in enteric neurons of different parts of colon. After tetrodotoxin, IB-MECA caused circular muscle relaxation. The data support the novel concept that eADO acts at low-affinity A3 receptors in addition to high-affinity A1 receptors to suppress coordinated responses triggered by immune-histamine H2 receptor activation. The short interplexus circuit activated by histamine involves adenosine, acetylcholine, substance P, and serotonin. We postulate that A3 receptor modulation may occur in gut inflammatory diseases or allergic responses involving mast cell and histamine release.

Indexed as

Gastrointestinal MotilityNeural InhibitionAdenosineAnimalsChloridesCimetidineColonDihydropyridinesDimapritDose-Response Relationship, DrugEnteric Nervous SystemGuinea PigsHistamineHistamine AgonistsHistamine H2 AntagonistsIntestinal Secretions1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine2-chloro-N(6)cyclopentyladenosine8-cyclopentyl-1,3-dimethylxanthine8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthineAdenosineChloridesCimetidineDihydropyridinesDimapritHistamineHistamine AgonistsHistamine H2 AntagonistsMecamylamineMRS 1191N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosineNeurokinin-1 Receptor AntagonistsNicotinic AntagonistsPiperidinesPropaneReceptor, Adenosine A1Receptor, Adenosine A3Receptors, Histamine H2Receptors, Neurokinin-1RS 39604TheophyllineXanthines

Identifiers

PMID19808660
PMCPMC2850084
OpenAlexW2015572364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.